Posts in tag
Remicade
PI change on the agenda
TGA issues safety reminder and advises of updates to infliximab product information Changes to the product information of Remicade (infliximab) have been flagged by the TGA in a recent newsletter, …
All content on AJP.com.au is restricted to registered users only.
To continue enjoying access to all the news, views, information and education you’ve come to trust, please login & stay in.
And if you don’t already have a login – register now!